Friday, July 4, 2025

Creating liberating content

Introducing deBridge Finance: Bridging...

In the dynamic landscape of decentralized finance (DeFi), innovation is a constant,...

Hyperliquid Airdrop: Everything You...

The Hyperliquid blockchain is redefining the crypto space with its lightning-fast Layer-1 technology,...

Unlock the Power of...

Join ArcInvest Today: Get $250 in Bitcoin and a 30% Deposit Bonus to...

Claim Your Hyperliquid Airdrop...

How to Claim Your Hyperliquid Airdrop: A Step-by-Step Guide to HYPE Tokens The Hyperliquid...
HomePoliticsNew Covid-19 variants...

New Covid-19 variants force production of new versions of vaccines

The so-called FLiRT variants are the most common variants of Covid-19 this year, according to the World Health Organization. Reuters. One of them, called KP.2, it became the most common variant in the United States (US) in April.

FLiRT variants include the parental JN.1 lineage and have three major antibody evasion mutations. Infectious Diseases Society of the United States spokesman Aaron Glatt noted “significant changes in variants,” although there has been a decline in hospitalizations related to Covid-19, “likely due to the immunity that many, many people already have.” It has”.

The number of antiviral drugs (Paxlovid) prescribed for the virus has dropped by about 60% compared to last year. The current vaccines “should still provide some benefit” over the new variants, Aaron Glatt said.

In April, Europe’s health regulator identified the JN.1 variant as a target for the production of new versions of vaccines. In the US, regulators will meet with experts to discuss the vaccination project on June 5.

Pfizer and Moderna are awaiting the verdict of the meeting. Meanwhile, Novavax began production of the anti-JN.1 drug in accordance with the recommendations of European regulators.

Author: morning Post
Source: CM Jornal

Get notified whenever we post something new!

Continue reading